3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Melanoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Squamous Intraepithelial Lesions
1
Prostatic Neoplasms
1
Liver Diseases
1
Interventions
VGX-3100
3
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
epigallocatechin gallate
1
Restraint, Physical
1
Radiofrequency Ablation
1
Human Papillomavirus DNA Tests
1
GPI0100
1
Electroporation
1
Colposcopy
1
Antigens
1
Adjuvants, Pharmaceutic
1
5-aminolaevulinic acid-n-pentylester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Squamous Intraepithelial Lesions
×
Electroporation
×
Clear all
NCT03185013
2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3
Completed
201 enrolled
23 charts